93 related articles for article (PubMed ID: 14752232)
1. Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
Wajima T; Makita S; Oshima K
Pharmacology; 2004 Mar; 70(3):123-9. PubMed ID: 14752232
[TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
4. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
5. [Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits].
Oogushi K
Fukuoka Igaku Zasshi; 1991 Feb; 82(2):36-47. PubMed ID: 2022360
[TBL] [Abstract][Full Text] [Related]
6. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
Watanabe N; Ishikawa Y; Okamoto R; Watanabe Y; Fukuzaki H
Artery; 1987; 14(5):283-94. PubMed ID: 3662844
[TBL] [Abstract][Full Text] [Related]
8. Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Harsch M; Gebhardt A; Reymann A; Lang G; Schliack M; Löser R; Braesen JH; Niendorf A
Br J Pharmacol; 1998 May; 124(2):277-82. PubMed ID: 9641543
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T
Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
[TBL] [Abstract][Full Text] [Related]
11. Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Wajima T; Makita S; Oshima K
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):958-62. PubMed ID: 14678236
[TBL] [Abstract][Full Text] [Related]
12. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
[TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
Fukuo Y; Nagashima M; Saitoh A; Kobayashi Y; Terashi A; Nakama K; Kameyama K; Asano G
Clin Ther; 1991; 13(3):417-24. PubMed ID: 1954642
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.
Aoki T; Yamazaki H; Suzuki H; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2001; 51(3):197-203. PubMed ID: 11304935
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels. In vivo study using low density lipoprotein receptor deficient watanabe heritable hyperlipidemic rabbits.
Shiomi M; Shiraishi M; Yata T; Ito T
Arzneimittelforschung; 1994 Oct; 44(10):1154-6. PubMed ID: 7818592
[TBL] [Abstract][Full Text] [Related]
16. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.
Hussain MM; Innerarity TL; Brecht WJ; Mahley RW
J Biol Chem; 1995 Apr; 270(15):8578-87. PubMed ID: 7721759
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
18. Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous watanabe hyper lipidemic rabbits.
Pauletto P; Puato M; Faggin E; Sartore S
J Vasc Res; 2000; 37(3):189-94. PubMed ID: 10859477
[TBL] [Abstract][Full Text] [Related]
19. EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit.
Tavridou A; Kaklamanis L; Papalois A; Kourounakis AP; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG
J Pharmacol Exp Ther; 2007 Dec; 323(3):794-804. PubMed ID: 17804677
[TBL] [Abstract][Full Text] [Related]
20. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
